Stock Report

Download full stock data and analysis for free Last Updated: 29-Aug-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

Serious stock insights. No fluff. No FOMO.

Recently Viewed

Clear All

Jagsonpal Pharma Peer Comparison

Stock Card factsheet watchlist-stock-modal share-fund-plan-icon

NSE: JAGSNPHARM | BSE: 507789

₹239.06

up-down-arrow ₹2.07 (0.87%)

As on 28-Aug-2026IST

Market cap

info icon

₹1,582 Cr

Revenue (TTM)

info icon

₹294 Cr

P/E Ratio

info icon

34.8

P/B Ratio

info icon

6.3

Div. Yield

info icon

1.7 %

Edit peer-selector-edit
Jagsonpal Pharma Pfizer Caplin Point Lab Eris Lifesciences Astrazeneca Pharma
Market cap (₹ Cr)
 1,582 21,501 19,125 18,253 17,766
Revenue (₹ Cr)
 294 2,570 2,287 3,230 2,432
Net Profit (₹ Cr)
 45.48 735.15 678.07 666.92 169.62
Net Margin (%)
 14.87 26.88 28.10 20.60 6.90
RoE (%)
 17.79 19.16 19.73 18.75 20.76
Price to Earnings
 34.79 29.25 28.74 28.35 104.74
Price-To-Book
 6.31 4.88 5.08 4.51 19.65

Income Statement (₹ Cr)

Jagsonpal Pharma Pfizer Caplin Point Lab Eris Lifesciences Astrazeneca Pharma
Operating Revenue arrow
293.85 2,569.77 2,287.33 3,229.67 2,432.06
Total Income arrow
305.85 2,735.39 2,413.29 3,237.12 2,458.54
Total Expenditure arrow
232.74 1,628.14 1,490.75 2,090.06 2,202.20
EBITDA arrow
61.10 941.63 796.58 1,139.61 229.86
Depreciation arrow
9.23 57.58 78.10 281.06 17.24
EBIT arrow
51.87 884.05 718.48 858.55 212.62
Interest arrow
1.03 7.69 0.88 190.64 5.72
Other Income arrow
12.00 165.62 125.96 7.45 26.48
Exceptional Items arrow
-2.08 -49.16 0.00 -17.24 -5.13
Profit before Tax arrow
60.77 992.82 843.56 658.12 228.25
Provision for Tax arrow
15.29 257.67 165.49 -8.80 58.63
Profit after Tax arrow
45.48 735.15 678.07 666.92 169.62

Liabilities (₹ Cr)

Jagsonpal Pharma Pfizer Caplin Point Lab Eris Lifesciences Astrazeneca Pharma
Shareholder's Funds arrow
276.17 4,202.90 3,586.42 3,902.67 872.79
Minority Interest arrow
0.00 0.00 -12.71 -21.81 0.00
Non-Current Liabilities arrow
12.21 91.50 28.74 1,392.75 134.50
Current Liabilities arrow
28.30 627.48 385.94 2,077.10 981.81
Total Liabilities arrow
291.83 4,911.11 3,207.85 6,862.28 1,879.19

Assets (₹ Cr)

Jagsonpal Pharma Pfizer Caplin Point Lab Eris Lifesciences Astrazeneca Pharma
Non-Current Assets arrow
78.53 770.28 1,291.22 5,617.77 42.47
Current Assets arrow
143.09 3,803.22 2,585.66 1,539.85 1,739.93
Total Assets arrow
291.83 4,911.11 3,207.85 6,862.28 1,879.19
Total Debt* arrow
0.00 2.50 0.55 2,421.66 0.00
Net Current Assets arrow
114.79 3,175.74 2,199.72 -537.25 758.12
Contingent Liabilities arrow
16.17 363.79 0.64 64.29 98.41

Cashflow (₹ Cr)

Jagsonpal Pharma Pfizer Caplin Point Lab Eris Lifesciences Astrazeneca Pharma
Cash From Operating Activities arrow
55.30 659.75 432.37 1,065.01 65.36
Cash Flow from Investing Activities arrow
-45.15 -71.34 -334.73 -79.97 30.80
Cash from Financing Activities arrow
-11.70 -205.34 -38.32 -881.32 -65.59
Net Cash Inflow / Outflow arrow
-1.55 383.07 59.32 103.72 30.57

Ratios

Profitability Ratios

 Jagsonpal Pharma Pfizer Caplin Point Lab Eris Lifesciences Astrazeneca Pharma
ROCE (%) arrow
33.14 26.21 26.22 13.59 21.29
ROE (%) arrow
17.79 19.16 19.73 18.75 20.76
ROA (%) arrow
15.29 14.95 18.69 9.26 9.67
EBIT Margin (%) arrow
17.65 34.40 31.41 26.58 8.74
Net Margin (%) arrow
14.87 26.88 28.10 20.60 6.90
Cash Profit Margin (%) arrow
0.00 0.00 0.00 0.00 0.00

Growth Ratios

 Jagsonpal Pharma Pfizer Caplin Point Lab Eris Lifesciences Astrazeneca Pharma
Revenue Growth (%) arrow
3.87 10.69 15.01 9.59 31.10
EBIT Growth (%) arrow
13.66 24.14 18.45 16.84 -12.99
Net Profit Growth (%) arrow
-25.24 -9.09 19.61 62.68 -7.49
EPS Growth (%) arrow
-20.48 14.40 17.73 67.41 -18.33
Book Value Growth (%) arrow
27.98 17.30 23.77 10.19 7.70

Valuation Ratios

 Jagsonpal Pharma Pfizer Caplin Point Lab Eris Lifesciences Astrazeneca Pharma
Price / Earnings arrow
33.92 27.87 28.74 27.66 102.37
Price / Book Value arrow
6.31 4.88 5.08 4.51 19.65
Dividend Yield (%) arrow
1.67 1.60 0.16 0.55 0.51
EV/EBITDA arrow
23.79 19.53 22.88 17.94 75.34
Market Cap (₹ Cr) arrow
1,433.90 18,318.10 15,219.80 19,292.77 21,515.93

Solvency Ratios

 Jagsonpal Pharma Pfizer Caplin Point Lab Eris Lifesciences Astrazeneca Pharma
Debt to Equity arrow
0.00 0.00 0.00 0.24 0.00
Short term debt to equity ratio arrow
-- 0.00 0.00 0.14 --
Current Ratio arrow
5.06 6.06 6.70 0.74 1.77
Quick Ratio arrow
4.54 5.31 5.59 0.53 0.73
Interest Coverage arrow
60.28 130.11 959.59 4.45 40.90

Operating Efficiency Ratios

 Jagsonpal Pharma Pfizer Caplin Point Lab Eris Lifesciences Astrazeneca Pharma
Debtors to sales (%) arrow
5.85 7.07 36.10 21.07 8.79
Asset Turnover arrow
0.99 0.52 0.63 0.45 1.39
Receivable days arrow
15.63 29.10 110.70 54.07 35.81
Inventory Days arrow
19.56 69.53 65.86 32.16 82.25
Payable days arrow
32.80 76.77 105.88 140.91 124.39
Cash Conversion Cycle arrow
2.39 21.86 70.68 -54.68 -6.33
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...